rood blauwe elepsis logo Belegger.nl

Esperite (voorheen Cryo Save) Terug naar discussie overzicht

Esperite - 2020: stuiptrekkingen

2.232 Posts
Pagina: «« 1 ... 79 80 81 82 83 ... 112 »» | Laatste | Omlaag ↓
  1. forum rang 10 DeZwarteRidder 12 oktober 2020 12:51
    quote:

    Optieskoper schreef op 12 oktober 2020 12:47:

    Afgaande op Snaar komt hij over 5 dagen met een Plan de Campagne Ultimo :-)
    Snaartje gaat waarschijnlijk zelf de tent uit het faillissement redden.
  2. bik 12 oktober 2020 13:22
    Tsja,als niemand anders het dan kan,lijkt hij me inderdaad de juiste persoon om deze klus te klaren.Ga er gelijk 1million bijrollen als dat zo blijkt te gaan zijn. grrr.
  3. [verwijderd] 12 oktober 2020 14:30
    quote:

    Optieskoper schreef op 12 oktober 2020 12:47:

    Afgaande op Snaar komt hij over 5 dagen met een Plan de Campagne Ultimo :-)
    Het zijn woorden die blackie hier zelf heeft neergekladdert overigens.. :-)
  4. Amarillo 12 oktober 2020 14:56
    quote:

    bik schreef op 12 oktober 2020 13:22:

    Tsja,als niemand anders het dan kan,lijkt hij me inderdaad de juiste persoon om deze klus te klaren.Ga er gelijk 1million bijrollen als dat zo blijkt te gaan zijn. grrr.
    Bik..wat is je plan...eerst komen dan eruit kukken...
  5. forum rang 10 DeZwarteRidder 12 oktober 2020 14:59
    quote:

    Amarillo schreef op 12 oktober 2020 14:56:

    [...]Bik..wat is je plan...eerst komen dan eruit kukken...
    Bik gooit More geld in het water.....................
  6. [verwijderd] 12 oktober 2020 15:15
    ESPERITE : Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions
    ACTUS NEWS•29/07/2020 à 09:45

    Transaction highlights

    · Esperite NV secures an external financing of up to EUR 35 million through further private placements of convertible notes with share subscription warrants attached over a period of 36 months, subject to fulfillment of certain conditions

    · The Warrants, if exercised, are leading to an additional EUR 35 million proceeds over a period of 5 years

    · Bridge note of EUR 150,000 issued today

    · Subscription by European Small Caps Opportunities Fund, based in Australia

    · Before the end of September Esperite will convene a Shareholder Extraordinary General Meeting.

    · Esperite will propose a settlement to its creditors

    · Proceeds to be used to support Esperite' s restructuring plan to be approved by creditors

    The Netherlands, 28 July 2020 - Esperite N.V. (Euronext: ESP, "Esperite" or "the Issuer") announces today (i) the issuance of a bridge note of EUR 150,000 nominal value (the "Bridge Note") and (ii) the signing of a financing agreement allowing Esperite to draw up to EUR 35 million (the "Financing") private placement of convertible notes with share subscription warrants attached under certain conditions (the "Notes and Warrants") and having the characteristics detailed in Appendix 1 (the "Issuance Agreement").

    The Bridge Note (issued) and the Notes and Warrants shall be subscribed by European Small Cap Opportunities Fund, a fund based in Australia (the "Investor").

    The Bridge Note financing shall allow Esperite to initiate next steps of restructuring.

    With regards to the Financing, the first tranche of Notes and Warrants of a nominal amount of EUR 400,000 shall be issued after the approval of resolutions by the general meeting of shareholders of the Issuer and approval by Esperite' s creditors of a settlement amount to be paid overtime by the Issuer for their debt (the "Restructuring Plan Approval").

    The second tranche of Notes and Warrants of a nominal amount of EUR 500,000 shall be issued after the approval of a prospectus by the AFM with regards to the new shares to be issued upon conversion of the Notes and exercise of the Warrants.

    Pursuant to the Issuance Agreement, the Investor has committed to subscribe up to EUR 35 million of Notes and Warrants over the next 36 months, subject to the fulfillment of certain conditions (the "Commitment").

    The issuance of and subscription to Notes and Warrants shall be structured through the issuance by Esperite to the Investor of tranche warrants (the "Tranche Warrants") within 5 trading days from the Restructuring Plan Approval, whose characteristics are described in Appendix 1 to this press release.

    The terms and conditions of the Tranche Warrants, the Notes and the Warrants will be published on Esperite's website (www.esperite.com).
  7. forum rang 10 DeZwarteRidder 12 oktober 2020 15:18
    quote:

    Snaarwegger schreef op 12 oktober 2020 15:15:

    ESPERITE : Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions
    ACTUS NEWS•29/07/2020 à 09:45

    Transaction highlights

    · Esperite NV secures an external financing of up to EUR 35 million through further private placements of convertible notes with share subscription warrants attached over a period of 36 months, subject to fulfillment of certain conditions

    · The Warrants, if exercised, are leading to an additional EUR 35 million proceeds over a period of 5 years

    · Bridge note of EUR 150,000 issued today

    · Subscription by European Small Caps Opportunities Fund, based in Australia

    · Before the end of September Esperite will convene a Shareholder Extraordinary General Meeting.

    · Esperite will propose a settlement to its creditors

    · Proceeds to be used to support Esperite' s restructuring plan to be approved by creditors

    The Netherlands, 28 July 2020 - Esperite N.V. (Euronext: ESP, "Esperite" or "the Issuer") announces today (i) the issuance of a bridge note of EUR 150,000 nominal value (the "Bridge Note") and (ii) the signing of a financing agreement allowing Esperite to draw up to EUR 35 million (the "Financing") private placement of convertible notes with share subscription warrants attached under certain conditions (the "Notes and Warrants") and having the characteristics detailed in Appendix 1 (the "Issuance Agreement").

    The Bridge Note (issued) and the Notes and Warrants shall be subscribed by European Small Cap Opportunities Fund, a fund based in Australia (the "Investor").

    The Bridge Note financing shall allow Esperite to initiate next steps of restructuring.

    With regards to the Financing, the first tranche of Notes and Warrants of a nominal amount of EUR 400,000 shall be issued after the approval of resolutions by the general meeting of shareholders of the Issuer and approval by Esperite' s creditors of a settlement amount to be paid overtime by the Issuer for their debt (the "Restructuring Plan Approval").

    The second tranche of Notes and Warrants of a nominal amount of EUR 500,000 shall be issued after the approval of a prospectus by the AFM with regards to the new shares to be issued upon conversion of the Notes and exercise of the Warrants.

    Pursuant to the Issuance Agreement, the Investor has committed to subscribe up to EUR 35 million of Notes and Warrants over the next 36 months, subject to the fulfillment of certain conditions (the "Commitment").

    The issuance of and subscription to Notes and Warrants shall be structured through the issuance by Esperite to the Investor of tranche warrants (the "Tranche Warrants") within 5 trading days from the Restructuring Plan Approval, whose characteristics are described in Appendix 1 to this press release.

    The terms and conditions of the Tranche Warrants, the Notes and the Warrants will be published on Esperite's website (www.esperite.com).
    Oud nieuws was toch verboden....!!!???

    Het is wel duidelijk dat Snaartje er niks van begrijpt.
2.232 Posts
Pagina: «« 1 ... 79 80 81 82 83 ... 112 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.154
AB InBev 2 5.544
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.437
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.925
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.885
Aedifica 3 927
Aegon 3.258 323.193
AFC Ajax 538 7.092
Affimed NV 2 6.306
ageas 5.844 109.908
Agfa-Gevaert 14 2.074
Ahold 3.538 74.356
Air France - KLM 1.025 35.317
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.057
Alfen 16 25.464
Allfunds Group 4 1.522
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 426
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.214
AMG 972 134.670
AMS 3 73
Amsterdam Commodities 305 6.753
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.102
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.072
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.373
Aroundtown SA 1 221
Arrowhead Research 5 9.752
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.686
ASML 1.767 111.879
ASR Nederland 21 4.521
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.294
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.462